Phase II study of nafoxidine in the therapy for advanced renal carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009256:Nafoxidine / Q000009:adverse effects / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D011759:Pyrrolidines / Q000627:therapeutic use*
D011759:Pyrrolidines; D009256:Nafoxidine